The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest news from CDMOs, CMOs, and suppliers featuring news from Alcami, Covance, WuXi Advanced Therapies, Comar, and Argonaut.
Chemicals/Chemical API Manufacturing
Alcami Sells API Mfg Facility in Netherlands to MercachemSyncom
Alcami, CDMO...
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi STA, Joinn Biologics, and Colorcon.
Chemicals/Chemical API Manufacturing
WuXi STA Opens Oligonucleotide Mfg Facility in China
WuXi STA, a subsidiary of WuXi AppTec, has...
The latest news from CDMOs, CMOs, and suppliers featuring news from AGC Biologics, Avantor, Fujifilm, Sartorius, AMRI, Symbiosis and PCI Pharma.
Biologics Manufacturing
AGC Biologics To Expand Plasmid DNA Offering
AGC Biologics, a CDMO for...
Charles River Laboratories, a contract research organization, has agreed to acquire HemaCare, a producer of human-derived cellular products for cell therapy, for approximately $380 million. The proposed purchase price equates to $25.40 per HemaCare...
3M has agreed to sell substantially all of its drug-delivery business (except its transdermal drug-delivery component business) to an affiliate of the investment firm, Altaris Capital Partners, for $650 million.
As part of the transaction, 3M will...
Cambrex, a CMO of small-molecule active pharmaceutical ingredients and drug products, has been acquired by an affiliate of Permira Funds, private-equity firm, for approximately $2.4 billion, including Cambrex’s net debt. The companies had announced...
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi AppTec, Lubrizol, Delpharm, and Arranta Bio.
Biologics Manufacturing
Arranta Bio Acquires Captozyme for Microbiome Development and Clinical Supply
Arranta Bio, a new CDMO...
WuXi Vaccines, a subsidiary WuXi Biologics focused on contract development and manufacturing services for vaccines, is investing $240 million to build a new vaccine-manufacturing facility in Ireland. This investment follows a 20-year manufacturing...
Fujifilm Diosynth Biotechnologies (FDB), a contract biologics manufacturer, has announced the expansion of its gene-therapy services with the addition of dedicated process and analytical development laboratories. As part of a capital investment of...
Lonza has announced that Marc Funk, Chief Executive Officer (CEO), will leave the company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of CEO on an interim...
Recipharm, a CDMO of active pharmaceutical ingredients (APIs) and drug products, has agreed to acquire Consort Medical, the parent company of Aesica, a CDMO of APIs and drug products, and Bespak, a CDMO of drug devices, for £505 million ($652...
The latest news from CDMOs, CMOs, and suppliers featuring news from ACG Biologics, Thermo Fisher Scientific, Recipharm, Aptar, West, Schott, and Heraeus.
Chemicals/Chemical API Manufacturing
China’s Raybow Acquires US-Based API Manufacturer...
Fujifilm plans to invest approximately JPY 13 billion ($120 million) in gene-therapy laboratories and manufacturing for its contract development and manufacturing business.
The investment will include the addition of dedicated gene-therapy...
Arranta Bio, a new CDMO that focuses on the human microbiome, has completed an $82 million funding round and formed a strategic partnership with Thermo Fisher Scientific.
Arranta was formed in May 2019 to provide live biopharmaceutical products...
The latest news from CDMOs, CMOs, and suppliers featuring news from WuXi Biologics, Lonza, Vetter, Sterling Pharma Solutions, and Bio-Techne.
Chemicals/Chemical API Manufacturing
Sterling Pharma To Invest $1.5 Million in Small-Scale Mfg and...
